期刊文献+

HIV感染者、发病者及HAART治疗者NK细胞亚群变化研究 被引量:4

Alteration of NK cell subsets in HIV-infected Chinese
下载PDF
导出
摘要 目的探讨HIV感染者、发病者和进行高效抗逆转录病毒疗法(HAART)的治疗者NK细胞亚群的变化情况。方法取新鲜外周全血,用荧光标记的单克隆抗体进行染色,经流式细胞仪检测分析HIV感染者、发病者和HAART治疗者NK细胞亚群的变化。结果 HIV感染者、发病者CD56dimCD16+NK细胞的百分比显著低于HIV抗体阴性健康对照;CD56-CD16+、CD56briCD16-/+NK细胞的百分比显著高于HIV抗体阴性健康对照;HAART治疗者CD56dimCD16+、CD56-CD16+和CD56briCD16-/+NK细胞亚群的百分比与HIV抗体阴性健康对照相比不再有显著差异。结论 HIV感染改变了NK细胞亚群的构成,HAART治疗后NK细胞亚群的比例可得到部分恢复。 To investigate changes of NK cell subsets in HIV-infected Chinese patients,PBMCs were collected from four groups representing different stages of HIV disease:asymptomatic chronically infected HIV patients,AIDS patients,HIV-positive patients receiving highly active antiretroviral therapy(HAART),and HIV-negative controls.PBMCs were stained with fluorescent monoclonal antibodies for the NK cell subsets.Three distinct subpopulations(CD56-CD16+,CD56dimCD16+ and CD56briCD16-/+) of NK cells were quantified by flow cytometer and compared among the groups.The percentage of CD56dimCD16+ NK cells was decreased significantly,while the percentage of CD56-CD16+ and CD56briCD16-/+ NK cells were increased significantly in HIV group and AIDS group.The percentage of CD56dimCD16+,CD56-CD16+,and CD56briCD16-/+ NK cells in HAART treatment group revealed no significant differences compared to any of the groups.Our results indicate that HIV infection changes the composition of NK cell subsets,and this change can be partially restored by HAART treatment.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第7期557-560,共4页 Immunological Journal
基金 国家科技重大专项课题资助项目(2008ZX10001-001) 国家重点基础研究发展计划(2006CB504206) 辽宁省教育厅高等学校创新团队项目(辽教发[2008]117号)
关键词 NK细胞 亚群 HIV AIDS HAART NK cells subsets HIV AIDS HAART
  • 相关文献

参考文献17

  • 1Levy JA. The importance of the innate immune system in controlling HIV infection and disease [J]. Trends Immunol, 2001, 22(6): 312-316.
  • 2郑晓群,吕建新.KIR2DL分子的研究进展[J].免疫学杂志,2004,20(z1):106-108. 被引量:2
  • 3Papamichail M, Perez SA, Gritzapis AD, et al. Natural killer Lymphocytes: biology development, and function [J]. Cancer Immunol Immunother, 2004, 53(3): 176-186.
  • 4Aher G, Rihn S, Walter K, et al. HLA class I subtype-dependent expansion of KIR3DS1 and KIR3DL1 NK cells during acute human immunodeficiency virus type 1 infection [J]. J Virol, 2009, 83(13): 6798-6805.
  • 5Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors [J]. Blood, 2009, 114(13): 2657-2666.
  • 6Caligiuri MA. Human natural killer cells [J]. Blood, 2008, 112(3): 461-469.
  • 7Chan A, Hong DL, Atzberger A, et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts [J]. J Immunol, 2007, 179: 89-94.
  • 8Romagnani C, Juelke K, Falco M, et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56^dim NK cells upon activation [J]. J Immunol, 2007, 178(8): 4947-4955.
  • 9Poli A, Tatiana M, Theresine M, et al. CD56^bright natural killer (NK) cells: an important NK cell subset [J]. Immunology, 126: 458-465.
  • 10Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset [J]. Blood, 2001, 97(10): 3146-3151.

二级参考文献33

  • 1颜卫华.NK细胞受体KIR2DL4的结构与功能[J].免疫学杂志,2003,19(S1):53-56. 被引量:3
  • 2[1]Steffens U, Vyas Y, Dupont B, et al. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR) [J]. Tissue Antigens, 1998, 51(4): 398-413.
  • 3[2]Wilson MJ, Torkar M, Haude A, et al. Plasticity in the organization and sequences of human KIR/ILT gene families [J]. PNAS, 2000, 97(9): 4 778 - 4 785.
  • 4[5]Winter CC, Gumperz JE, Parham P, et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition [J]. J Immunol,1998, 161(2): 571 - 577.
  • 5[6]Fan QR, Garboczi DN, Winter CC, et al. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class Ⅰ major histocompatibility complex molecule [J]. PNAS, 1996,93(14):7 178-7 183.
  • 6[8]Vilches C, Rajalingam R, Uhrberg M, et al. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains [J]. J Immunol, 2000, 164(11):5 797-5 804.
  • 7[9]Morro SM, Samanridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition of human natural killer cells [J] . Science, 1995,268 (1):405 - 408.
  • 8[10]Su RC,Kung S K, Gariepy J, et al. NK cells can recognize different forms of class I MHC [ J ] . J Immunol, 1998,161(2) :755 - 766.
  • 9[11]Fan QR, Long EO, Wiley DC, et al. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLACw4 complex [J]. Nat Immunol,2001,2(5):452- 460.
  • 10[12]Richardson J, Reyburn HT, Luque I, et al. Definition of polymorphic residues on killer Ig-like receptor proteins, which contribute to the HLA-C binding site [J]. Eur J Immunol,2000,30(5): 1 480 - 1 485.

共引文献4

同被引文献66

  • 1黄俊,吴长有.CD107a/b分子用于评价SARS-CoV/S抗原特异性免疫应答[J].免疫学杂志,2009,25(2):161-164. 被引量:3
  • 2Poli A,Michel T,Theresine M,et al.CD56bright natural killer (NK) cells:an important NK cell subset[J].Immunology,2009,126(4):458-465.
  • 3Hong HS,Eberhard JM,Keudel P,et al.Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16 + natural killer cells in HIV infection[J].AIDS,2010,24(12):1823-1834.
  • 4Chan A,Hong DL,Atzberger A,et al.CD56bright human NK cells differentiate into CD56dim cells:role of contact with peripheral fibroblasts[J].J Immunol,2007,179(1):89-94.
  • 5Freud AG,Caligiuri MA.Human natural killer cell development[J].Immunol Rev,2006,214:56-72.
  • 6Zhang AL,Colmenero P,Purath U,et al.Natural killer cells trigger differentiation of monocytes into dendritic cells[J].Blood,2007,110(7):2484-2493.
  • 7Altfeld M,Fadda L,Frleta D,et al.DCs and NK cells:critical effectors in the immune response to HIV-1[J].Nat Rev Immunol,2011,11(3):176-186.
  • 8Bielekova B,Catalfamo M,Reichert-Scrivner S,et al.Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis[J].Proc Natl Acad Sci USA,2006,103 (15):5941-5946.
  • 9Eller MA,Eller LA,Ouma BJ,et al.Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection[J].J Acquir Immune Defic Syndr,2009,51 (4):380-389.
  • 10Titanji K,Sammicheli S,De Milito A,et al.Altered distribution of natural killer cell subsets identified by CD56,CD27 and CD70in primary and chronic human immunodeficiency virus-1 infection[J].Immunology,2008,123(2):164-170.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部